e-learning
resources
Barcelona 2013
Saturday, 07.09.2013
PG7 Tuberculosis: innovations in clinical and public health management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The ERS European Forum for TB Innovation in Europe: a new way to raise innovation
G.B. Migliori (Tradate, Italy)
Source:
Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management
Session:
PG7 Tuberculosis: innovations in clinical and public health management
Session type:
Postgraduate Course
Number:
43
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G.B. Migliori (Tradate, Italy). The ERS European Forum for TB Innovation in Europe: a new way to raise innovation. Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
The ERS European Forum for TB Innovation
Source: Annual Congress 2013 –ERS/WHO joint lunchtime session "TB-Forum for innovation"
Year: 2013
Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe},
Source: Eur Respir J 2012; 40: 806-808
Year: 2012
Health Research collaboration in Europe: an innovative initiative
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013
The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP)
Source: Eur Respir J, 49 (5) 1602295; 10.1183/13993003.02295-2016
Year: 2017
Research priorities in Europe: the 2019 ERS Presidential Summit action plan
Source: International Congress 2019 – Chinese programme 2019: Part I
Year: 2019
The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level
Source: Eur Respir J 2008; 31: 924-926
Year: 2008
The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation
Source: Eur Respir J, 53 (1) 1802089; 10.1183/13993003.02089-2018
Year: 2019
European reference networks: moving towards a tangible outcome of the European Union's cross-border healthcare directive?
Source: Eur Respir J 2016; 48: 1564-1568
Year: 2016
Better Medicines for Children - European regulation, European research networks, Funding opportunities
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006
Answering the research gaps on MDR-TB in Europe: the results of the FP7 - funded TB PAN-NET project
Source: Annual Congress 2012 - Fighting MDR- and XDR-TB in Europe: from programme results to research implementation
Year: 2012
Asthma research in Europe: a transformative agenda for innovation and competitiveness
Source: Eur Respir J, 49 (5) 1602294; 10.1183/13993003.02294-2016
Year: 2017
The Alliance for biomedical research in Europe
Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Year: 2014
New opportunities for respiratory research in Europe: FP7
Source: Eur Respir J 2007; 29: 223-225
Year: 2007
ERS is founding member of a new Alliance for Biomedical Research in Europe
Source: Eur Respir J 2011; 38: 237-238
Year: 2011
European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis
Source: Eur Respir J 2002; 19: 765-775
Year: 2002
The European Respiratory Society plans its future: the 2013–2018 strategic plan
Source: Eur Respir J 2014; 43: 927-932
Year: 2014
The European Union standards for tuberculosis care: do they need an update?
Source: Eur Respir J 2014; 43: 933-942
Year: 2014
Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes
Source: Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept